Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab monitoring in Crohn's disease patients failing infliximab therapy
2009-009926-94Phase 4Completed
- Sponsor
- Herlev Hospital
- Start
- Feb 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of infliximab in Crohn's disease, sponsored by Herlev Hospital. Primary endpoint: Primary clinical response at week 12. Started Feb 2009; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2009-009926-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009926-94.